Development
BioXcel Therapeutics, Inc.
BTAI
$1.84
$0.3120.26%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -61.28% | -45.37% | -17.42% | -16.84% | -8.14% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 43.32% | 37.99% | 186.22% | -- | -- |
| Prepaid Expenses | -30.06% | -55.89% | -9.28% | 6.20% | 37.14% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -10.66% | 173.83% | 238.70% | 301.99% | -- |
| Total Current Assets | -59.14% | -43.56% | -14.60% | -14.33% | -5.94% |
|
|
|||||
| Total Current Assets | -59.14% | -43.56% | -14.60% | -14.33% | -5.94% |
| Net Property, Plant & Equipment | -27.24% | -25.61% | -24.15% | -18.93% | -15.71% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -90.59% | -90.59% | -4.15% | 975.58% | -47.29% |
| Total Assets | -58.97% | -43.56% | -14.66% | -14.03% | -6.32% |
|
|
|||||
| Total Accounts Payable | 81.69% | 86.07% | 52.85% | 118.64% | 70.75% |
| Total Accrued Expenses | 66.81% | 71.10% | 96.88% | 94.70% | 55.42% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.65% | 8.50% | 8.70% | -- | 8.71% |
| Total Finance Division Other Current Liabilities | 20.69% | 2.71% | 30.60% | -71.93% | 206.03% |
| Total Other Current Liabilities | 20.69% | 2.71% | 30.60% | -71.93% | 206.03% |
| Total Current Liabilities | 68.57% | 73.76% | 79.78% | 97.38% | 60.17% |
|
|
|||||
| Total Current Liabilities | 68.57% | 73.76% | 79.78% | 97.38% | 60.17% |
| Long-Term Debt | 8.07% | 58.57% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -39.06% | -34.98% | -31.61% | -28.87% | -26.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.19% | 3.68% | -- | -- | -- |
| Total Liabilities | 19.71% | 59.85% | 646.54% | 626.30% | 646.91% |
|
|
|||||
| Common Stock & APIC | 9.10% | 9.29% | 9.77% | 4.46% | 3.98% |
| Retained Earnings | -59.32% | -64.44% | -67.47% | -67.44% | -62.40% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -131.98% | -96.43% | -72.68% | -65.36% | -48.29% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -131.98% | -96.43% | -72.68% | -65.36% | -48.29% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -131.98% | -96.43% | -72.68% | -65.36% | -48.29% |
|
|
|||||